COMPARATIVE ANALYSIS OF DIFFERENT MANUFACTURERS KITS FOR DETERMINING CLASS G ANTIBODIES TO MEASLES VIRUS
- Authors: Ermolaeva D.E1, Zherdeva P.E.1, Toptygina A.P.1,2, Smerdova M.A.3, Shershneva N.N.4
-
Affiliations:
- G.N.Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Russia
- Chair of Immunology, Faculty of Biology, Lomonosov Moscow State University
- JSC Vector-Best-Europe, Moscow, Russia
- LLC Rapid Bio, Moscow, Russian Federation
- Section: Forum Sochi 2026
- Submitted: 12.04.2026
- Accepted: 21.07.2026
- URL: https://rusimmun.ru/jour/article/view/17503
- DOI: https://doi.org/10.46235/1028-7221-17503-CAO
- ID: 17503
Cite item
Full Text
Abstract
Relevance. The implementation of the WHO-declared goal of measles elimination requires a well-established system of epidemiological surveillance and monitoring of population immunity levels, which must be at least 95%. Therefore, high accuracy of serological tests for identifying susceptible individuals is critically important, particularly in the range of low values approaching the "gray zone." Widely used ELISA test systems from various manufacturers, which have replaced the WHO-recommended Enzygnost (Siemens) test systems, exhibit variable sensitivity, potentially leading to underestimation of measles-susceptible individuals in population immunity studies.
Objective. To compare the results of measles virus IgG antibody detection by ELISA using kits from four different manufacturers.
Materials and Methods. Blood serum samples from 88 measles patients were tested. Four kits intended for quantitative and qualitative determination of IgG antibodies to the measles virus were used: VectoMeasles-IgG (Vector-Best), ELISA-Measles-IgG (Ecolab), Rapid-Measles-IgG-ELISA (Rapid Bio), and Anti-Measles Virus ELISA (IgG) (Euroimmun). The test systems differed in the measles virus antigens employed and in the cut-off thresholds used to classify results as positive or negative. Both qualitative and quantitative analyses of the results were performed, with antibody concentrations calculated in IU/mL. Data processing was carried out using nonparametric statistics and Pearson correlation analysis.
Results. Among the four test systems, the Rapid kit yielded the highest number of indeterminate results. Ecolab produced the highest number of positive results (64 samples, 72.7%), while Euroimmun produced the lowest number of positive sera (46 samples, 52.3%). In the high-value range, all kits identified all sera with high IgG levels. Substantial differences were observed in the low and equivocal value ranges. The best agreement was demonstrated by the Vector-Best/Euroimmun and Rapid/Euroimmun pairs (90% concordance). Vector-Best/Rapid showed 83% concordance. Ecolab/Vector-Best yielded 77%, Ecolab/Euroimmun 76%, and Ecolab/Rapid 70%.
Conclusion. High comparability of results obtained using different test systems is essential for establishing an accurate picture of population immunity. The observed discrepancies are largely attributable to differing cut-off thresholds for result classification. The greatest disagreements occur precisely in the range of low and equivocal values. When a result falls within this problematic zone, retesting the sample using an alternative test system is advisable.
Keywords
About the authors
Daria E Ermolaeva
G.N.Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Russia
Email: dariatsatsura@yandex.ru
ORCID iD: 0009-0008-8920-3133
SPIN-code: 5522-8821
Junior Researcher, Laboratory of Cytokines
Russian Federation, 10 Admiral Makarov Street, Moscow, 125212, RussiaPolina E. Zherdeva
G.N.Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Russia
Email: polya-zherdeva@mail.ru
ORCID iD: 0000-0002-7635-4353
SPIN-code: 1675-7056
Scopus Author ID: 57665765500
Researcher, Laboratory of Cytokines
Russian FederationAnna P. Toptygina
G.N.Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Russia;Chair of Immunology, Faculty of Biology, Lomonosov Moscow State University
Email: toptyginaanna@rambler.ru
ORCID iD: 0000-0002-9981-4762
SPIN-code: 8523-5018
Scopus Author ID: 6602424818
ResearcherId: В-6725-2019
DSc (Medicine), Assistant Professor, Head Research, Head of Laboratory of Cytokines,
Professor, Department of Immunology, Faculty of Biology
Russian Federation, 10 Admiral Makarov Street, Moscow, 125212, RussiaMarina A. Smerdova
JSC Vector-Best-Europe, Moscow, Russia
Email: biologsmerdova@yandex.ru
ORCID iD: 0000-0003-3821-8809
SPIN-code: 3070-7065
PhD (Biology), Leading Product Specialist
Russian Federation, 1011B, Sosenskoye settlement, Nikolo-Khovanskoye village, 108802, Moscow, RussiaNatalia N. Shershneva
LLC Rapid Bio, Moscow, Russian Federation
Author for correspondence.
Email: nshershneva@drbiotech.ru
ORCID iD: 0009-0002-6991-3302
SPIN-code: 9550-1168
PhD (Biology), Leading research scientist in the field of ELISA
Russian Federation, Skolkovo Innovation Center, Bolshoy Boulevard, 42, building 1, 121205 Moscow, RussiaReferences
- В.В. Белякова, О.А. Майорова, Н.В. Иванова, И.Е. Степанова, М.А. Смердова, А.П. Обрядина, А.П. Топтыгина «Оценка серологических тестов на антитела к различным антигенам вируса SARS-CoV-2. Сопоставление шести тест-систем» // Медицинская иммунология, 2021. Т. 23, № 6. С. 1395-1404. V.V. Belyakova, O.A. Maiorova, N.V. Ivanova, I.E. Stepanova, M.A. Smerdova, A.P. Obryadina, A.P. Toptygina Assessment of serological tests for antibodies to different antigens of the SARS-CoV-2 virus: comparison of six immunoassays //Medical Immunology (Russia)=Meditsinskaya Immunologiya, 2021, Vol. 23, no. 6, pp. 1395-1404. (In Russ.) doi: 10.15789/1563-0625-AOS-22
- Cho H.K., Lee H., Kim H.W., Kim S.S., Kang H..J, Kim I.T., Kim K.H. Seroprevalences of Specific IgG Antibodies to Measles, Mumps, and Rubella in Korean Infants. J Korean Med Sci, 2016, Vol.31(12), pp.1957–1962 doi: 10.3346/jkms.2016.31.12.195
- Cohen B.J., Doblas D., Andrews N. Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination. Vaccine, 2008, Vol.26(50), pp.6392–6397 doi: 10.1016/j.vaccine.2008.08.074
- Cohen B.J., Parry R.P., Doblas D., Samuel D., Warrener L., Andrews N., Brown D. Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralization assay. J Virol Methods, 2006, Vol.131, pp. 209 –212. doi: 10.1016/j.jviromet.2005.08.001.
- Coughlin M.M., Beck A.S., Bankamp B., Rota P.A. Perspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination Strategies. Viruses, 2017, Vol.9(1), pp.11 doi: 10.3390/v901001
- Coughlin M.M., Matson Z., Sowers S.B., Priest J.W., Smits G.P., van der Klis F.R.M., Mitchell A., Hickman C.J., Scobie H.M., Goodson J.L., Alexander J.P. Jr, Rota P.A., Bankamp B. Development of a Measles and Rubella Multiplex Bead Serological Assay for Assessing Population Immunity. J Clin Microbiol., 2021, Vol.59(6), pp.e02716-e2720 doi: 10.1128/JCM.02716-2
- Cutts F.T., Hanson M. Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countries. Trop Med Int Health., 2016, Vol.21(9), pp.1086–1098 doi: 10.1111/tmi.12737.
- Dorigo-Zetsma J.W., Leverstein-van Hall M.A., Vreeswijk J., de Vries J.J., Vossen A.C., Ten Hulscher H.I., Kerkhof J., Smits G.P., Ruijs W.L., Koopmans M.P., Binnendijk R.S. Immune status of health care workers to measles virus: evaluation of protective titers in four measles IgG EIAs. J Clin Virol, 2015, Vol.69, pp.214 –218. doi: 10.1016/j.jcv.2015.06.095.
- Hatchette T.F., Scholz H., Bolotin S., Crowcroft N.S., Jackson C., McLachlan E., Severini A. Calibration and Evaluation of Quantitative Antibody Titers for Measles Virus by Using the BioPlex 2200. Clin Vaccine Immunol, 2017, Vol.24(1), pp.e00269-e00316 doi: 10.1128/CVI.00269-16.
- Latner D.R., Sowers S.B., Anthony K., Colley H., Badeau C., Coates J., Wong P., Fakile Y., Interiano C., Pannell K.B., Leung-Pineda V., Patel M.M., Rota P.A., Limbago B.M., Hickman C.J. Qualitative variation among commercial immunoassays for detection of measlesspecific IgG. J Clin Microbiol, 2020, Vol. 58, pp.e00265-00720. doi: 10.1128/JCM.00265-20.
- Lessler J., Metcalf C..J, Cutts F.T., Grenfell B.T. Impact on Epidemic Measles of Vaccination Campaigns Triggered by Disease Outbreaks or Serosurveys: A Modeling Study. PLoS Med., 2016, Vol.13(10), pp.e1002144. doi: 10.1371/journal.pmed.1002144
- Lutz C. S., Hasan A. Z., Bolotin S., Crowcroft N. S., Cutts F. T., Joh E., Loisate S., Moss W. J., Osman S., Hayford K. Comparison of measles IgG enzyme immunoassays (EIA) versus plaque reduction neutralization test (PRNT) for measuring measles serostatus: a systematic review of head to head analyses of measles IgG EIA and PRNT. BMC Infectious Diseases. 2023, Vol. 23, pp.367 doi: 10.1186/s12879-023-08199-8
- Pugh S., Fosdick B.K., Nehring M., Gallichotte E.N., VandeWoude S., Wilson A. Estimating cutoff values for diagnostic tests to achieve target specificity using extreme value theory. BMC Medical Research Methodology, 2024, Vol. 24, pp.30 doi: 10.1186/s12874-023-02139-5
- Science M., Savage R., Severini A., McLachlan E., Hughes S.L., Arnold C., Richardson S, Crowcroft N, Deeks S, Halperin S, Brown K, Hatchette T, Gubbay J, Mazzulli T, Bolotin S. Measles Antibody Levels in Young Infants. Pediatrics, 2019,Vol.144(6), pp.e20190630 doi: 10.1542/peds.2019-0630.
- Zubach V, Beirnes J, Hayes S, Severini A, Hiebert J. Diagnostic accuracy of commercially available serological tests for the detection of measles and rubella viruses: a systematic review and meta-analysis. J Clin Microbiol., 2024, Vol.62(2) , pp. e0133923. doi: 10.1128/jcm.01339-23
Supplementary files


